Recombinant Mouse IL-23R protein (His Tag)
Species
Mouse
Purity
>90 %, SDS-PAGE
Tag
His Tag
Activity
not tested
Cat no : Eg0808
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Mouse IL-23R protein Gly24-Gly374 (Accession# Q8K4B4) with a His tag at the C-terminus. |
GeneID | 209590 |
Accession | Q8K4B4 |
PredictedSize | 41.5 kDa |
SDS-PAGE | 50-80 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Interleukin-23 receptor (IL23R) is a type I cytokine receptor that plays a pivotal role in the immune system, particularly in the maturation and function of T helper 17 (Th17) cells. IL23R, along with IL12Rβ1, forms the receptor complex necessary for IL-23 signaling, which is critical for the production of IL-17 and the activation of pro-inflammatory activities. This receptor is expressed on various immune cells, including T cells, NK cells, dendritic cells, and macrophages. Research has shown that variations in the IL-23R gene can significantly influence susceptibility to several diseases, particularly inflammatory bowel diseases such as ulcerative colitis (UC) and Crohn's disease (CD). In addition to UC, IL-23R has been implicated in other inflammatory conditions, including rheumatoid arthritis and ankylosing spondylitis.
References:
1.Mezghiche I, et al. (2024)Eur J Immunol. 54 (1):e2250348. 2.Peng LL, et al.(2017) Oncotarget. 8 (3):4849-4863. 3.Hamdy G, et al. (2015). Hum Immunol. 76 (6):417-20.